Form 4: Mirum Pharmaceuticals Director Michael G. Grey Donates Shares to Charity

Director Michael G. Grey of Mirum Pharmaceuticals gifted 102,788 shares of common stock to The Children's Hospital of Philadelphia Foundation on September 27, 2024.

Summary

• On September 27, 2024, Michael G. Grey, a director at Mirum Pharmaceuticals, donated 102,788 shares of common stock to The Children's Hospital of Philadelphia Foundation.
• Following the transaction, Mr. Grey directly owns no shares but indirectly owns 186,410 shares through The Grey Family Trust dated November 12, 1999, and 93,750 shares through The Grey 2018 Irrevocable Children's Trust.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive due to the charitable donation, which is generally viewed favorably. There are no indications of negative financial implications.

Positives

• A director of Mirum Pharmaceuticals made a charitable donation of company stock to The Children's Hospital of Philadelphia Foundation.

Industry Context

Charitable donations of stock by company insiders are not uncommon and can be viewed positively by the market, especially when directed towards reputable organizations.

Comparison to Industry Standards

• Comparing this transaction to similar insider donations in the pharmaceutical industry, the size of the donation is moderate.
• For example, directors at companies like Pfizer and Johnson & Johnson have made similar donations to charitable organizations in the past.
• The impact on Mirum's stock price is likely to be minimal, as such donations are typically not viewed as a reflection of the company's financial health or future prospects.

Stakeholder Impact

• The donation benefits The Children's Hospital of Philadelphia Foundation.
• The impact on shareholders is likely neutral, as the transaction does not directly affect the company's operations or financial performance.

Key Dates